Nesivine Pädiatrie Sine Conservans (Oxymetazoline Hydrochloride)

Oxymetazoline Hydrochloride, the active ingredient in Nesivine Pädiatrie Sine Conservans, is an alpha‑adrenergic agonist presented as a nasal solution for intranasal use. It provides temporary relief of nasal congestion in children and adults.

GNH USA supplies Nesivine Pädiatrie Sine Conservans as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxymetazoline Hydrochloride is a topical nasal decongestant that reduces swelling of the nasal mucosa.

- Nasal congestion: provides rapid, temporary relief of blocked nose caused by colds, sinusitis or allergic rhinitis. - Common cold: eases breathing difficulty associated with upper respiratory viral infections. - Allergic rhinitis: diminishes nasal blockage due to seasonal or perennial allergens.

Oxymetazoline Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation. - Dryness of the nasal passages. - Sneezing or mild epistaxis. - Headache. - Transient taste disturbance. - Rebound congestion with prolonged use.

Serious or Rare Side Effects: - Severe hypertension or hypertensive crisis. - Cardiac arrhythmias. - Nasal ulceration or necrosis. - Anaphylactic reaction. - Vision changes or ocular pressure increase. - Persistent severe headache.

Before using Oxymetazoline Hydrochloride, consider the following safety measures.

- Limit duration of use: do not exceed three consecutive days to avoid rebound congestion. - Pre‑existing cardiovascular disease: use with caution and monitor blood pressure. - Diabetes or thyroid disorders: consult a healthcare professional before use. - Children under a certain age: follow age‑specific recommendations on the product label. - Pregnancy and breastfeeding: discuss potential risks with a physician. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Oxymetazoline Hydrochloride can interact with other medications that affect blood pressure or adrenergic pathways.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may cause excessive hypertensive response. - Other nasal decongestants: risk of additive vasoconstriction and rebound effects. - Tricyclic antidepressants: can potentiate cardiovascular stimulation.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt the systemic cardiovascular response. - Clonidine or other antihypertensives: monitor for additive blood pressure changes. - Sympathomimetic agents: assess for cumulative adrenergic effects.